For Dementia Action Week, WMG at the University of Warwick, together with Superlunary Labs, are doubling their efforts to develop a low-cost, non-intrusive method for the early screening of Alzheimer’s Disease using a simple flavour test which can be undertaken as part of a regular health check-up by a nurse, at a pharmacy or community centre.

The test can help diagnose the beginnings of Alzheimer's years before symptoms of memory loss through a loss of taste or smell.

Scientists at Warwick are looking to get data from at least 1000 people before aiming to roll the screening out nationwide, potentially as early as next year. If you want to take part in the trial, and can get to the University of Warwick campus, contact Warwick to be part of the future of medicine.

Professor Alan Chalmers commented: “Working with MPs and their constituency offices we will be collecting more data across the country to significantly enlarge our dataset of people’s flavour perception ability. This dataset, together with AI and MRI scans, will enable us to validate our screening method. Once validated we will be able to roll out the method widely, hopefully as early as next year.

New drugs that slow disease progression down offer real hope to people living with Alzheimer’s Disease, but crucially the disease needs early diagnosis for these drugs to be most effective. One might have the disease many years before failing a memory test, the current means for diagnosing Alzheimer’s Disease”.

Notes to Editor

Contact press@warwick.ac.uk if you wish to take part in the trial.